США - англійська - NLM (National Library of Medicine)

seqirus pty ltd - influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) antigen (propiolactone inactivated) (unii: 9jwn7vdq7n) (influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) hemagglutinin antigen (propiolactone inactivated) - unii:u6c4gj6wzg), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (propiolactone inactivated) (unii: a5wli8wk8a) (influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) hemagglutinin antigen (propiolactone inactivated) - unii:37h6eg2naq), influenza b vi - influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) hemagglutinin antigen (propiolactone inactivated) 15 ug in 0.5 ml - afluria® is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes a and type b present in the vaccine. afluria is approved for use in persons 5 years of age and older. afluria is contraindicated in individuals with known severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine including egg protein, or to a previous dose of any influenza vaccine (see description [11]) . pregnancy category b: a reproductive and developmental toxicity study has been performed in female rats at a dose approximately 265 times the human dose (on a mg/kg basis) and revealed no evidence of impaired female fertility or harm to the fetus due to afluria. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, afluria should be given to a pregnant woman only if clearly needed. in the reproductive and developmental toxicity study, the effect

США - англійська - NLM (National Library of Medicine)

seqirus inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) (unii: q3p251c5mt) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:ld80h821hf) - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) 15 ug in 0.5 ml

США - англійська - NLM (National Library of Medicine)

seqirus inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (propiolactone inactivated) (unii: v8pc20ubcn) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (propiolactone inactivated) - unii:wlsrj8jc6s) - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (propiolactone inactivated) 15 ug in 0.5 ml

США - англійська - NLM (National Library of Medicine)

catalent belgium sa - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (propiolactone inactivated) (unii: v8pc20ubcn) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (propiolactone inactivated) - unii:wlsrj8jc6s) - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (propiolactone inactivated) 15 ug in 0.5 ml

США - англійська - NLM (National Library of Medicine)

asclemed usa, inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (mdck cell derived, propiolactone inactivated) (unii: qwjhw3wexs) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) - unii:55qh9pjkdv), influenza a virus a/singapore/gp2050/2015 (h3n2) antigen (mdck cell derived, propiolactone inactivated) (unii: hrt2x6kfjo) (influenza a virus a/singapore/gp2050/2015 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone ina -

США - англійська - NLM (National Library of Medicine)

boiron - influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) hemagglutinin antigen (formaldehyde inactivated) (unii: w929z18nv6) (influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:w929z18nv6), influenza b virus b/maryland/15/2016 bx-69a antigen (formaldehyde inactivated) (unii: m691j375mm) (influenza b virus b/maryland/15/2016 bx-69a antigen (formaldehyde inactivated) - unii:m691j375mm), influenza a virus a/michigan/45/2015 x-275 ( - relieves after effects of flu or flu-like symptoms relieves after effects of flu or flu-like symptoms stop use and ask a doctor if symptoms persist for more than 3 days or worsen

Сінгапур - англійська - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the model npl3800 lead has application where implantable atrial or ventricular, single-chamber or dual-chamber pacing systems are indicated. the model npl3800 lead is intended for pacing and sensing in the atrium or ventricle.

Сінгапур - англійська - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the model npl5000 lead is designed to be used with a pulse generator as part of a cardiac pacing system. the lead has application where implantable atrial or ventricular, single chamber or dual chamber pacing systems are indicated.

Сінгапур - англійська - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the model npl4000 lead has application where implantable ventricular, single chamber or dual chamber pacing systems are indicated. the lead is intended for pacing and sensing in the ventricle.

Сінгапур - англійська - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the model npl4500 lead has application where implantable atrial, single chamber or dual chamber pacing systems are indicated. the lead is intended for pacing and sensing in the atrium.